AIP
HALO icon

Almanack Investment Partners’s Halozyme HALO Stock Holding History

Almanack Investment Partners’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,382
Closed -$55K – 594
2022
Q3 		$55K Buy
+1,382
New +$61.1K 0.01% 253

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Almanack Investment Partners's HALO Position: Q4 2022 in Review

Almanack Investment Partners sold out of Halozyme (HALO) in Q4 2022, closing a stake of 1,382 shares — an estimated $55K sold.

Almanack Investment Partners first reported a position in HALO in Q3 2022 and held it in 1 quarter. The position peaked at $55K in Q3 2022. 423 funds tracked by Wall St. Rank hold HALO as of Q4 2022.

  • Almanack Investment Partners reported no remaining Halozyme position as of Q4 2022 after selling out during the quarter.
  • Almanack Investment Partners sold 1,382 Halozyme shares in Q4 2022, an estimated $55K.
  • Almanack Investment Partners first reported a position in Halozyme in Q3 2022 and held it in 1 quarter.
  • Almanack Investment Partners's Halozyme position peaked at $55K in Q3 2022.
  • 423 funds tracked by Wall St. Rank held Halozyme as of Q4 2022.

Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.